HUNTINGTON BEACH, Calif.– Life Science Intelligence (LSI) today announced a multi-year collaboration with Mednovation, an industry hub for executives, entrepreneurs and investors working to finance and grow medtech ventures in China. Together, Mednovation and LSI will foster innovation and expand support for medtech leaders in the Chinese ecosystem.
As LSI’s preferred partner in China, Mednovation will support LSI events, market intelligence products, research services, and other strategic initiatives in China. Mednovation will continue to support and be integrated into LSI’s marquee Emerging Medtech Summits across North America and Europe, and will support LSI in expanding the Emerging Medtech Summit event family globally.
“China’s ecosystem presents a tremendous opportunity to advance medtech innovation and continue our efforts towards saving patient lives and improving the standard of care globally” said Scott Pantel, CEO of LSI. “With partnering events and market intelligence services trusted by global medtech leaders, we are excited to take another step in expanding our community. We look forward to working with Mednovation to engage, support, and develop China’s active medtech innovation ecosystem.”
“We are thrilled to join forces with LSI and become their preferred partner in China,” said William Jin, Partner at Mednovation. “The cooperation between our companies will help us best support LSI’s global expansion efforts, medtech leaders that are exploring the Chinese market, medtech leaders in the Chinese market today, and the members of Mednovation seeking to access international markets and resources.”
The announcement comes after “LSI Europe 2022,” the first Emerging Medtech Summit outside of the United States. The event featured internationally acclaimed keynote speakers like Bernd Montag, CEO of Siemens Healthineers, and Antoine Papiernik, Managing Partner of Sofinnova Partners. The three-day summit took place at The Grove, a historic countryside retreat outside of London, England.
